logo

PYXS

Pyxis Oncology·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
5.50 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is PYXS a Good Buy Right Now?
  • Based on a composite score of 5.50/10, we rate PYXS as a Netural. Our analysis breaks down into 6.60/10 for Fundamentals, 3.61/10 for Technicals, and 5.89/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is PYXS undervalued or overvalued?
Technical Analysis of PYXS?
Is money flowing into or out of PYXS?